Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Cua

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
AIDS Research and Therapy|January 16, 2022
Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trialNolwenn Hall, Clotilde Allavena, Christine Katlama, et al.
Frontiers in Medicine|February 15, 2021
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 PatientsCaroline Ruetsch, Vesna Brglez, Marion Crémoni, et al.
AIDS (London, England)|February 10, 2022
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxisJérémy Zeggagh, Rebecca Bauer, Constance Delaugerre, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 4, 2021
Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY TrialJulie Chas, Rebecca Bauer, Islam Amine Larabi, et al.
Malaria Journal|August 25, 2009
Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case reportChristelle Pomares-Estran, Pascal Delaunay, Annie Mottard, et al.
Open Forum Infectious Diseases|March 23, 2019
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and QuebecAntoine Chaillon, Constance Delaugerre, Bluma Brenner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2020
Prevalence and Incidence of Human Papillomavirus Infection in Men Having Sex With Men Enrolled in a Pre-exposure Prophylaxis Study: A Sub-study of the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales "Intervention Préventive de l'Exposition aux Risques avec et pour les hommes Gays" TrialLaurent Cotte, David Veyer, Isabelle Charreau, et al.
The Lancet. HIV|December 18, 2018
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trialJoseph J Eron, Jean-Daniel Lelievre, Robert Kalayjian, et al.
Journal of the American Heart Association|September 25, 2020
High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019Emile Ferrari, Benjamin Sartre, Fabien Squara, et al.
The Lancet. HIV|July 28, 2017
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort studyJean-Michel Molina, Isabelle Charreau, Bruno Spire, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
AIDS Research and Therapy|January 16, 2022
Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trialNolwenn Hall, Clotilde Allavena, Christine Katlama, et al.
Frontiers in Medicine|February 15, 2021
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 PatientsCaroline Ruetsch, Vesna Brglez, Marion Crémoni, et al.
AIDS (London, England)|February 10, 2022
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxisJérémy Zeggagh, Rebecca Bauer, Constance Delaugerre, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 4, 2021
Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY TrialJulie Chas, Rebecca Bauer, Islam Amine Larabi, et al.
Malaria Journal|August 25, 2009
Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case reportChristelle Pomares-Estran, Pascal Delaunay, Annie Mottard, et al.
Open Forum Infectious Diseases|March 23, 2019
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and QuebecAntoine Chaillon, Constance Delaugerre, Bluma Brenner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2020
Prevalence and Incidence of Human Papillomavirus Infection in Men Having Sex With Men Enrolled in a Pre-exposure Prophylaxis Study: A Sub-study of the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales "Intervention Préventive de l'Exposition aux Risques avec et pour les hommes Gays" TrialLaurent Cotte, David Veyer, Isabelle Charreau, et al.
The Lancet. HIV|December 18, 2018
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trialJoseph J Eron, Jean-Daniel Lelievre, Robert Kalayjian, et al.
Journal of the American Heart Association|September 25, 2020
High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019Emile Ferrari, Benjamin Sartre, Fabien Squara, et al.
The Lancet. HIV|July 28, 2017
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort studyJean-Michel Molina, Isabelle Charreau, Bruno Spire, et al.
Pageof 5